These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32846814)

  • 1. Next-generation sequencing identifies a novel heterozygous I229T mutation on LMNA associated with familial cardiac conduction disease.
    Gao Y; Han Z; Wu X; Lan R; Zhang X; Shen W; Liu Y; Liu X; Lan X; Xu B; Xu W
    Medicine (Baltimore); 2020 Aug; 99(34):e21797. PubMed ID: 32846814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Truncating LMNA Mutation in Patients with Cardiac Conduction Disorders and Dilated Cardiomyopathy.
    Kawakami H; Ogimoto A; Tokunaga N; Nishimura K; Kawakami H; Higashi H; Iio C; Kono T; Aono J; Uetani T; Nagai T; Inoue K; Suzuki J; Ikeda S; Okura T; Ohyagi Y; Tabara Y; Higaki J
    Int Heart J; 2018 May; 59(3):531-541. PubMed ID: 29628476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole exome sequencing identified a pathogenic nonsense mutation in LMNA in a family with a progressive cardiac conduction defect: A case report.
    Fan P; Zhang D; Yang KQ; Tian T; Luo F; Liu YX; Wang LP; Zhou XL
    Mol Med Rep; 2020 Jun; 21(6):2459-2465. PubMed ID: 32323820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and functional characterization of a novel mutation in lamin a/c gene in a multigenerational family with arrhythmogenic cardiac laminopathy.
    Forleo C; Carmosino M; Resta N; Rampazzo A; Valecce R; Sorrentino S; Iacoviello M; Pisani F; Procino G; Gerbino A; Scardapane A; Simone C; Calore M; Torretta S; Svelto M; Favale S
    PLoS One; 2015; 10(4):e0121723. PubMed ID: 25837155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of Lamin A/C at serine 22 modulates Na
    Olaopa MA; Ai T; Chao B; Xiao X; Vatta M; Habecker BA
    Physiol Rep; 2021 Nov; 9(22):e15121. PubMed ID: 34806324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Characterization of a Novel Truncating Mutation in Lamin A/C Gene in a Family with a Severe Cardiomyopathy with Conduction Defects.
    Gerbino A; Bottillo I; Milano S; Lipari M; Zio R; Morlino S; Mola MG; Procino G; Re F; Zachara E; Grammatico P; Svelto M; Carmosino M
    Cell Physiol Biochem; 2017; 44(4):1559-1577. PubMed ID: 29197877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case reports of a c.475G>T, p.E159* lamin A/C mutation with a family history of conduction disorder, dilated cardiomyopathy and sudden cardiac death.
    Yokokawa T; Ichimura S; Hijioka N; Kaneshiro T; Yoshihisa A; Kunii H; Nakazato K; Ishida T; Suzuki O; Ohno S; Aiba T; Ohtani H; Takeishi Y
    BMC Cardiovasc Disord; 2019 Dec; 19(1):298. PubMed ID: 31847799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-exome sequencing to identify a novel LMNA gene mutation associated with inherited cardiac conduction disease.
    Lai CC; Yeh YH; Hsieh WP; Kuo CT; Wang WC; Chu CH; Hung CL; Cheng CY; Tsai HY; Lee JL; Tang CY; Hsu LA
    PLoS One; 2013; 8(12):e83322. PubMed ID: 24349489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutation of the LMNA gene in a family with dilated cardiomyopathy, conduction system disease, and sudden cardiac death of young females.
    Chen W; Huo J; Ma A; Bai L; Liu P
    Mol Cell Biochem; 2013 Oct; 382(1-2):307-11. PubMed ID: 23793583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy.
    Parks SB; Kushner JD; Nauman D; Burgess D; Ludwigsen S; Peterson A; Li D; Jakobs P; Litt M; Porter CB; Rahko PS; Hershberger RE
    Am Heart J; 2008 Jul; 156(1):161-9. PubMed ID: 18585512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease.
    Wolf CM; Wang L; Alcalai R; Pizard A; Burgon PG; Ahmad F; Sherwood M; Branco DM; Wakimoto H; Fishman GI; See V; Stewart CL; Conner DA; Berul CI; Seidman CE; Seidman JG
    J Mol Cell Cardiol; 2008 Feb; 44(2):293-303. PubMed ID: 18182166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The K219T-Lamin mutation induces conduction defects through epigenetic inhibition of SCN5A in human cardiac laminopathy.
    Salvarani N; Crasto S; Miragoli M; Bertero A; Paulis M; Kunderfranco P; Serio S; Forni A; Lucarelli C; Dal Ferro M; Larcher V; Sinagra G; Vezzoni P; Murry CE; Faggian G; Condorelli G; Di Pasquale E
    Nat Commun; 2019 May; 10(1):2267. PubMed ID: 31118417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of machine learning to classify high-risk variants of uncertain significance in lamin A/C cardiac disease.
    Bennett JS; Gordon DM; Majumdar U; Lawrence PJ; Matos-Nieves A; Myers K; Kamp AN; Leonard JC; McBride KL; White P; Garg V
    Heart Rhythm; 2022 Apr; 19(4):676-685. PubMed ID: 34958940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel mutations in LMNA associated with familial forms of dilated cardiomyopathy.
    Stallmeyer B; Koopmann M; Schulze-Bahr E
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):543-9. PubMed ID: 22224630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac effects of the c.1583 C→G LMNA mutation in two families with Emery-Dreifuss muscular dystrophy.
    Zhang L; Shen H; Zhao Z; Bing Q; Hu J
    Mol Med Rep; 2015 Oct; 12(4):5065-71. PubMed ID: 26165385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel lamin A/C gene missense mutation (445 V > E) in immunoglobulin-like fold associated with left ventricular non-compaction.
    Liu Z; Shan H; Huang J; Li N; Hou C; Pu J
    Europace; 2016 Apr; 18(4):617-22. PubMed ID: 25829471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.
    van Tintelen JP; Hofstra RM; Katerberg H; Rossenbacker T; Wiesfeld AC; du Marchie Sarvaas GJ; Wilde AA; van Langen IM; Nannenberg EA; van der Kooi AJ; Kraak M; van Gelder IC; van Veldhuisen DJ; Vos Y; van den Berg MP;
    Am Heart J; 2007 Dec; 154(6):1130-9. PubMed ID: 18035086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LMNA mutations in Polish patients with dilated cardiomyopathy: prevalence, clinical characteristics, and in vitro studies.
    Saj M; Bilinska ZT; Tarnowska A; Sioma A; Bolongo P; Sobieszczanska-Malek M; Michalak E; Golen D; Mazurkiewicz L; Malek L; Walczak E; Fidzianska A; Grzybowski J; Przybylski A; Zielinski T; Korewicki J; Tesson F; Ploski R
    BMC Med Genet; 2013 May; 14():55. PubMed ID: 23702046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overlapping syndrome with familial partial lipodystrophy, Dunnigan variety and cardiomyopathy due to amino-terminal heterozygous missense lamin A/C mutations.
    Subramanyam L; Simha V; Garg A
    Clin Genet; 2010 Jul; 78(1):66-73. PubMed ID: 20041886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy.
    Perrot A; Hussein S; Ruppert V; Schmidt HH; Wehnert MS; Duong NT; Posch MG; Panek A; Dietz R; Kindermann I; Böhm M; Michalewska-Wludarczyk A; Richter A; Maisch B; Pankuweit S; Ozcelik C
    Basic Res Cardiol; 2009 Jan; 104(1):90-9. PubMed ID: 18795223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.